Alif Saleh, Scipher Medicine CEO
February 24, 2022 08:25 AM ESTUpdated 12:13 PM
Financing
Diagnostics

Pre­ci­sion im­munol­o­gy play­er bags $110M to fund its work on 'dis­ease sig­na­ture' tests

Paul Schloesser

Associate Editor

A Mass­a­chu­setts start­up is walk­ing away from its lat­est fi­nanc­ing haul with over $100 mil­lion in fresh cash, thanks to an in­vestor syn­di­cate back­ing their …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times